DIURETIC RESISTANCE AS A GENERAL CLINICAL PROBLEM
Abstract
Etiology, pathogenesis and treatment strategies in diuretic-resistant oedema are discussed
About the Authors
N. A. Mukhin
ГОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова Минздравсоцразвития России»
Russian Federation
Russian Federation
V. V. Fomin
ГОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова Минздравсоцразвития России»
Russian Federation
Russian Federation
A. A. Pulin
ГОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова Минздравсоцразвития России»
Russian Federation
Russian Federation
References
1. Al-Sheikh А.А.К., van der Heuvel Koenderink J.B., Russel FG.M. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4 / / Br. J. Pahrmacol. — 2008. — Vol. 155. - P. 1066-1075.
2. Bleich M., Greger R. Mechanism of action of diuretics / / Kidney Int. - 1997. - Vol. 51, suppl. 59. - P. S11-S15.
3. Boesken W.H., Kult J. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure / / Clin. Nephrol. — 1997. — Vol. 48, N 1. - P. 22-28.
4. Bramham K., Hunt B.J., Goldsmith D. Thrombophilia of nephrotic syndrome in adults / / Clin. Adv. Hematol. Oncol. - 2009. - Vol. 7, N 6. - P. 368-372.
5. Chui M.A., Deer M., Bennett S.J. et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure // Pharmacotherapy. — 2003. — Vol. 23, N 3. - P. 326-332.
6. Dougall H. T, Me Lay J. A comparative review of the adverse effects of calcium antagonists / / Drug Saf. — 1996. — Vol. 15, N 2 , - P.91-106.
7. Dunn C.J., FittonA., Brogden R.N. Torasemide. An updateof its pharmacological properties and therapeutic efficacy // Drugs. - 1995. - Vol. 49, N 1. - P. 121-142.
8. Fliser D., Schroter M., Neubeck M. et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure / / Kidney Int. — 1994. — Vol. 46, N 2. - P. 482-488.
9. Gehr T.W., Rudy D.W., Matzke G.R. et al. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency / / Clin. Pharmacol. Ther. — 1994. - Vol. 56, N 1. - P. 31-38.
10. Greenberg A. Diuretic complications //Am. J. Med. Sci. —* 2000. - Vol. 319, N 1. - P. 10-24.
11. Hunter D.J., York M., Chaisson C.E. et al. Recent diuretic use and the risk of recurrent gout attacks: the online casecrossover gout study / / J. Rheumatol. — 2006. — Vol. 33, N 7. - P. 1341-1345.
12. Kim E.J., Lee M.G. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats // Biopharm. Drug Dispos. — 2003. — Vol. 24, N 1. - P. 27-35.
13. Lyseng-Williamson K.A. Torasemide prolonged release // Drugs. - 2009. - Vol. 69, N 10. - P. 1363-13.72.
14. MacFadyen R.J., Gorski J.C., Brater D.C., Struthers A.D. Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study / / Br. J. Clin. Pharmacol. — 2004. — Vol. 57, N 5. - P. 622-631.
15. Muller K., Gamba G., Jaquet F., Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV — efficacy and quality of life / / Eur. J. Heart Fail. — 2003. — Vol. 5, N 6. — P. 793-801.
16. Orth S.R., Ritz E. The nephritic syndrome / / N. Engl. J. Med. - 1998. - Vol. 338. - P. 1202-1211.
17. Patel B.V., Remigio-Baker R.A., Thiebaud P. et al. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy // BMC Fam. Pract. — 2008. — Vol. 9. — P. 61.
18. Sukl W.N. Use of diuretics in chronic renal failure // Kidney Int. — 1997. — Vol. 51, suppl. 59. — P. S33—S35.
19. Taniguchi A., Kamatani N. Control of renal uric acid excretion and gout / / Curr. Opin. Rheumatol. — 2008. — Vol. 20, N 2. - P. 192-197.
20. Tesar V., Zima T., Kalousova M. Pathobiochemistry of nephrotic syndrome //Adv. Clin. Chem. — 2003. — Vol. 37. — P. 173—218.
21. Valentin J.P., Qiu C., Muldowney W.P. et al. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome // J. Clin. Invest. — 1992. — Vol. 90, N4. - P. 1302-1312.
Review
Views:
276
Email this article 